Role of voriconazole in combined acanthamoeba and fungal corneal ulcer

Contact Lens and Anterior Eye

Volumn 34, Issue 6, 2011, Pages 287-289

  Gupta, Shikha ^a   Shrivastava, Rajat Mohan ^a   Tandon, Radhika ^a   Gogia, Varun ^a   Agarwal, Prakashchand ^a   Satpathy, Gita ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acanthamoeba; Corneal ulcer; Fungal; Voriconazole

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFAZOLIN; CHLORHEXIDINE; EYE DROPS; MOXIFLOXACIN; NATAMYCIN; NEOSPORIN; PROPAMIDINE; TOBRAMYCIN; VORICONAZOLE;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; ADULT; ANTERIOR EYE CHAMBER; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; CONFOCAL LASER MICROSCOPY; CORNEA CULTURE; CORNEA SMEAR; CORNEA STROMA; CORNEA ULCER; CYST (RESTING STAGE); DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TREATMENT FAILURE; EYE EXAMINATION; FOLLOW UP; FUNGAL CORNEA ULCER; GROWTH INHIBITION; HUMAN; HYPOPYON; MALE; MICROBIOLOGICAL EXAMINATION; MIXED INFECTION; PARACENTESIS; PARASITE IDENTIFICATION; PRIORITY JOURNAL; REMISSION; SMEAR; TREATMENT RESPONSE; VISUAL ACUITY;

AMEBIASIS; AMEBICIDES; ANTIFUNGAL AGENTS; CORNEAL ULCER; EYE INFECTIONS, FUNGAL; EYE INFECTIONS, PARASITIC; HUMANS; MALE; PYRIMIDINES; TREATMENT OUTCOME; TRIAZOLES; YOUNG ADULT;

EID: 82655162227     PISSN: 13670484     EISSN: 14765411     Source Type: Journal    
DOI: 10.1016/j.clae.2011.06.004     Document Type: Article

References (23)

1. Manikandan P., Bhaskar M., Revathy R., John R.K., Narendran V., Panneerselvam K. Acanthamoeba keratitis-a six year epidemiological review from a tertiary care eye hospital in South India. Indian J Med Microbiol 2004, 22:226-230.
2. Sharma S., Garg P., Rao G.N. Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol 2000, 84:1103-1108.
3. Gupta N., Samantaray J.C., Duggal S., Srivastava V., Dhull C.S., Chaudhary U. Acanthamoeba keratitis with Curvularia co-infection. Indian J Med Microbiol 2010, 28:67-71.
4. Rumelt S., Cohen I., Lefler E., Rehany U. Corneal co-infection with Scedosporium apiospermum and Acanthamoeba after sewage-contaminated ocular injury. Cornea 2001, 20:112-116.
5. Slade D.S., Johnson J.T., Tabin G. Acanthamoeba and fungal keratitis in a woman with a history of Intacs corneal implants. Eye Contact Lens 2008, 34:185-187.
6. Bharathi M.J., Ramakrishnan R., Meenakshi R., Shivakumar C., Raj D.L. Analysis of the risk factors predisposing to fungal, bacterial & Acanthamoeba keratitis in south India. Indian J Med Res 2009, 130:749-757.
7. Sahu S.K., Das S., Sharma S., Vemuganti G.K. Acanthamoeba keratitis presenting as a plaque. Cornea 2008, 27:1066-1067.
8. Arnott M.A., Hay J., Seal D.V. Acanthamoeba keratitis: masquerading as adenovirus keratitis. Eye 1997, 11:570-571.
9. Clarke D.W., Alizadeh H., Niederkorn J.Y. Failure of Acanthamoeba castellanii to produce intraocular infections. Invest Ophthalmol Vis Sci 2005, 46:2472-2478.
10. Guerriero S., La Tegola M.G., Monno R., Apruzzese M., Cantatore A. A case of descemet's membrane rupture in a patient affected by Acanthamoeba Keratitis. Eye Contact Lens 2009, 35:338-340.
11. Dang Burgener N.P., Baglivo E., Farpour B., Brozou C., Dosso A., Safran A. Acanthamoeba detection in the anterior chamber. Br J Ophthalmol 2006, 90:649-650.
12. Mcclellan K., Coster D.J. Acanthamoebic keratitis diagnosed by paracentesis and biopsy and treated with propamidine. Br J Ophthalmol 1987, 71:734-736.
13. Amoils S.P., Heney C. Acanthamoeba keratitis with live isolates treated with cryosurgery and fluconazole. Am J Ophthalmol 1999, 127:718-720.
14. Al-Badriyeh D., Neoh C.F., Stewart K., Kong D.C. Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis. Clin Ophthalmol 2010, 4:391-405.
15. Prajna N.V., Mascarenhas J., Krishnan T., Reddy P.R., Prajna L., Srinivasan M., et al. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol 2010, 128:672-678.
16. Bang S., Edell E., Eghrari A.O., Gottsch J.D. Treatment with voriconazole in 3 eyes with resistant acanthamoeba keratitis. Am J Ophthalmol 2010, 149:66-69.
17. Lin H.C., Hsiao C.H., Ma D.H., Yeh L.K., Tan H.Y., Lin M.Y., et al. Medical treatment for combined Fusarium and Acanthamoeba keratitis. Acta Ophthalmol 2009, 87:199-203.
18. Kernt M., Kampik A. Intracameral voriconazole: in vitro safety for human ocular cells. Toxicology 2009, 258:84-93.
19. Thiel M.A., Zinkernagel A.S., Burhenne J., Kaufmann C., Haefeli W.E. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother 2007, 51:239-244.
20. Mathers W. Use of higher medication concentrations in the treatment of Acanthamoeba keratitis. Arch Ophthalmol 2006, 124:923.
21. Dart J.K., Saw V.P., Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol 2009, 148:487-499.
22. Gasset A.R., Ishii Y. Cytotoxicity of chlorhexidine. Can J Ophthalmol 1975, 10:98-100.
23. Rahman M.R., Minassian D.C., Srinivasan M., Martin M.J., Johnson G.J. Trial of chlorhexidine gluconate for fungal corneal ulcers. Ophthalmic Epidemiol 1997, 4:141-149.